Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,815
archived clinical trials in
Parkinsons Disease

A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/8/2016
830
mi
from
West Bloomfield, MI
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
830
mi
from
West Bloomfield, MI
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/8/2016
586
mi
from
Winfield, IL
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
586
mi
from
Winfield, IL
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/8/2016
801
mi
from
Atlanta, GA
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/8/2016
725
mi
from
Lexington, KY
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
725
mi
from
Lexington, KY
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/8/2016
1139
mi
from
Encinitas, CA
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1139
mi
from
Encinitas, CA
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/8/2016
1047
mi
from
Gainesville, FL
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1047
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/8/2016
726
mi
from
Cincinnati, OH
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
726
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/8/2016
895
mi
from
Cleveland, OH
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
895
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/8/2016
683
mi
from
Birmingham, AL
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
683
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/8/2016
1407
mi
from
Kirkland, WA
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1407
mi
from
Kirkland, WA
Click here to add this to my saved trials
Kinesia HomeView - Home Diary Comparison
Kinesia HomeView - Home Diary Comparison
Status: Enrolling
Updated:  1/8/2016
897
mi
from
Valley View, OH
Kinesia HomeView - Home Diary Comparison
Kinesia HomeView - Home Diary Comparison
Status: Enrolling
Updated: 1/8/2016
Great Lakes NeuroTechnologies Inc
897
mi
from
Valley View, OH
Click here to add this to my saved trials
Pilot Study for Automated Deep Brain Stimulation Programming
DBS-Expert: Automated Deep Brain Stimulation Programming Using Functional Mapping - Phase I
Status: Enrolling
Updated:  1/8/2016
726
mi
from
Cincinnati, OH
Pilot Study for Automated Deep Brain Stimulation Programming
DBS-Expert: Automated Deep Brain Stimulation Programming Using Functional Mapping - Phase I
Status: Enrolling
Updated: 1/8/2016
University of Cincinnati Department of Neurology
726
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration
Kinesia-D Phase II In-Clinic Continuous Assessment Study
Status: Enrolling
Updated:  1/8/2016
1149
mi
from
Baltimore, MD
Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration
Kinesia-D Phase II In-Clinic Continuous Assessment Study
Status: Enrolling
Updated: 1/8/2016
Johns Hopkins Medical Center
1149
mi
from
Baltimore, MD
Click here to add this to my saved trials
Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration
Kinesia-D Phase II In-Clinic Continuous Assessment Study
Status: Enrolling
Updated:  1/8/2016
1121
mi
from
Rochester, NY
Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration
Kinesia-D Phase II In-Clinic Continuous Assessment Study
Status: Enrolling
Updated: 1/8/2016
Univ of Rochester Medical Center
1121
mi
from
Rochester, NY
Click here to add this to my saved trials
Automated Telehealth Diagnostics for Remote Parkinson Monitoring
PDRemote Phase II: Automated Telehealth Diagnostics for Remote Parkinson Monitoring
Status: Enrolling
Updated:  1/8/2016
1121
mi
from
Rochester, NY
Automated Telehealth Diagnostics for Remote Parkinson Monitoring
PDRemote Phase II: Automated Telehealth Diagnostics for Remote Parkinson Monitoring
Status: Enrolling
Updated: 1/8/2016
University of Rochester
1121
mi
from
Rochester, NY
Click here to add this to my saved trials
Ancillary Longitudinal CSF Collection Study in the Harvard Biomarker Study - HBS2
Ancillary Longitudinal CSF Collection Study in the Harvard Biomarker Study - HBS2
Status: Enrolling
Updated:  1/11/2016
1443
mi
from
Boston, MA
Ancillary Longitudinal CSF Collection Study in the Harvard Biomarker Study - HBS2
Ancillary Longitudinal CSF Collection Study in the Harvard Biomarker Study - HBS2
Status: Enrolling
Updated: 1/11/2016
Massachusetts General Hospital
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)
Randomized Double Blind Placebo Controlled Cross-Over Study of Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  1/12/2016
1444
mi
from
Boston, MA
Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)
Randomized Double Blind Placebo Controlled Cross-Over Study of Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 1/12/2016
Beth Israel Deaconess Medical Center
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Cannabis and Parkinson's Disease Tremor: A Natural History Study
Cannabis and Parkinson's Disease Tremor: A Natural History Study
Status: Enrolling
Updated:  1/13/2016
1410
mi
from
Kenmore, WA
Cannabis and Parkinson's Disease Tremor: A Natural History Study
Cannabis and Parkinson's Disease Tremor: A Natural History Study
Status: Enrolling
Updated: 1/13/2016
Bastyr University
1410
mi
from
Kenmore, WA
Click here to add this to my saved trials
Intranasal Glutathione in Parkinson's Disease
A Phase 1 Study of Intranasal Reduced Glutathione in Parkinson's Disease
Status: Enrolling
Updated:  1/14/2016
1410
mi
from
Kenmore, WA
Intranasal Glutathione in Parkinson's Disease
A Phase 1 Study of Intranasal Reduced Glutathione in Parkinson's Disease
Status: Enrolling
Updated: 1/14/2016
Bastyr Clinical Research Center
1410
mi
from
Kenmore, WA
Click here to add this to my saved trials
The Effects of L-Tyrosine on 24 Hour Blood Pressure and Heart Rate in Parkinson's Disease
The Effects of L-Tyrosine on Non-invasive Ambulatory Blood Pressure and Heart Rate Monitoring in Parkinson's Disease
Status: Enrolling
Updated:  1/19/2016
1308
mi
from
Old Westbury, NY
The Effects of L-Tyrosine on 24 Hour Blood Pressure and Heart Rate in Parkinson's Disease
The Effects of L-Tyrosine on Non-invasive Ambulatory Blood Pressure and Heart Rate Monitoring in Parkinson's Disease
Status: Enrolling
Updated: 1/19/2016
New York Institute of Technology
1308
mi
from
Old Westbury, NY
Click here to add this to my saved trials
National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial
A Multi-center, Double-blind, Pilot Study of Minocycline and Creatine in Subjects With Early Untreated Parkinson's Disease
Status: Enrolling
Updated:  1/19/2016
1121
mi
from
Rochester, NY
National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial
A Multi-center, Double-blind, Pilot Study of Minocycline and Creatine in Subjects With Early Untreated Parkinson's Disease
Status: Enrolling
Updated: 1/19/2016
Univ of Rochester Medical Center
1121
mi
from
Rochester, NY
Click here to add this to my saved trials
The Long Term Impact of Initiating Pramipexole Versus Levodopa in Early Parkinson's Disease (CALM-PD Cohort Study)
Unblinded, Multicenter, Prospective Follow-up of Long-term Consequences of Initiating Patients With Parkinson's Disease on Either Pramipexole or Levodopa.
Status: Enrolling
Updated:  1/20/2016
1121
mi
from
Rochester, NY
The Long Term Impact of Initiating Pramipexole Versus Levodopa in Early Parkinson's Disease (CALM-PD Cohort Study)
Unblinded, Multicenter, Prospective Follow-up of Long-term Consequences of Initiating Patients With Parkinson's Disease on Either Pramipexole or Levodopa.
Status: Enrolling
Updated: 1/20/2016
University of Rochester
1121
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
683
mi
from
Birmingham, AL
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
University of Alabama at Birmingham, Dept. of Neurology
683
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
851
mi
from
Phoenix, AZ
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
Mohammed Ali Parkinson's Center
851
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
369
mi
from
Little Rock, AR
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
Clinical Trials, Inc.
369
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
1145
mi
from
La Jolla, CA
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
Coastal Neurological Medical Group
1145
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
1320
mi
from
Sunnyvale, CA
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
The Parkinson's Institute
1320
mi
from
Sunnyvale, CA
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
1176
mi
from
Torrance, CA
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
Collaborative Neuroscience Network, INC
1176
mi
from
Torrance, CA
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
402
mi
from
Aurora, CO
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
University of Colorado Health Sciences Center, School of Medicine
402
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
1344
mi
from
New Haven, CT
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
Yale Neurology Clinics, Temple Medical Center
1344
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
1131
mi
from
Bradenton, FL
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
Bradenton Research Center
1131
mi
from
Bradenton, FL
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
1309
mi
from
Hollywood, FL
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
Sunrise Clinical Research, Inc.
1309
mi
from
Hollywood, FL
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
1078
mi
from
Ocala, FL
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
Renstar Medical Research
1078
mi
from
Ocala, FL
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
1180
mi
from
Port Charlotte, FL
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
Charlotte Neurological Services Parkinson's Disease Treatment Center of S.W. Florida
1180
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
1177
mi
from
Port Charlotte, FL
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
University of S. Florida
1177
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
1114
mi
from
Saint Petersburg, FL
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
Suncoast Neuroscience Associates Inc
1114
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
935
mi
from
Augusta, GA
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
Medical College of Georgia, Movements Disorders Clinic
935
mi
from
Augusta, GA
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
1041
mi
from
Boise, ID
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
Idaho Elks Rehabilitation Hospital
1041
mi
from
Boise, ID
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
611
mi
from
Chicago, IL
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
Northwestern University, Feinberg School of Medicine, Dept. of Neurology
611
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
609
mi
from
Chicago, IL
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
Rush University Medical Center, Dept. of Neurological Sciences
609
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
346
mi
from
Des Moines, IA
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
Iowa Methodist Medical Center
346
mi
from
Des Moines, IA
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
196
mi
from
Kansas City, KA
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
Landon Center on Aging, Dept. of Neurology, Parkinson's Disease Center
196
mi
from
Kansas City, KA
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
834
mi
from
Bingham Farms, MI
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
QUEST Research Institute
834
mi
from
Bingham Farms, MI
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
1263
mi
from
New Brunswick, NJ
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
UMDNJ Robert Wood Johnson Medical Center, Department of Neurology
1263
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
1309
mi
from
Albany, NY
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
Albany Medical College
1309
mi
from
Albany, NY
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
1324
mi
from
Commack, NY
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
David L. Kreitzman, MD, P.C.
1324
mi
from
Commack, NY
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
1290
mi
from
New York, NY
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
Columbia University Neurological Institute
1290
mi
from
New York, NY
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
1049
mi
from
Durham, NC
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
Duke University Medical Center Movement Disorders Center
1049
mi
from
Durham, NC
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
1064
mi
from
Raleigh, NC
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
Raleigh Neurology Associates
1064
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/21/2016
725
mi
from
Cincinatti, OH
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/21/2016
University Neurology, Inc.
725
mi
from
Cincinatti, OH
Click here to add this to my saved trials